Cymabay Therapeutics Inc (CBAY) Gross Profit Margin starting from the fourth quarter 2023 to fourth quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Cymabay Therapeutics Inc   (NASDAQ: CBAY)


Cymabay Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CBAY Gross Profit Margin (Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $0.06
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 823
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2023 Gross Profit Margin



Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry 122 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
CBAY's Gross Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 123
Healthcare Sector # 207
Overall # 823

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Dec 31 2023)  




Other Gross Profit Margin Profitability Ratios
CBAY's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CBAY's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CBAY's Competitors
Gross Profit Margin Profit Margin for Cymabay Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for CBAY's Customers

You may also want to know
CBAY's Annual Growth Rates CBAY's Profitability Ratios CBAY's Asset Turnover Ratio CBAY's Dividend Growth
CBAY's Roe CBAY's Valuation Ratios CBAY's Financial Strength Ratios CBAY's Gross Profit Growth
CBAY's Roa CBAY's Inventory Turnover Ratio CBAY's Growth Rates CBAY's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2023 MRQ Gross ProfitDec 31 2023 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.